In summary, females generally mount stronger CD8+ effector T cell responses, producing more inflammatory molecules and differentiating faster into short‐lived effector cells, which may contribute to faster pathogen clearance and improved post‐infection outcomes compared to males. The gene discussed is CD8A; the disease is infection.